|
Legionella species
(Legionnaires’ disease)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1:
Susceptibility of Legionella spp. To Antimicrobial
Agents by In Vitro Agar Dilution Method.
Table 2:
Susceptibility of Legionella spp. To Antimicrobial
Agents by In Vitro Broth Dilution Method
Table 3:
Activity of Antimicrobial Agents Using In Vivo
Animal Model
Table 4:
Antibiotic Doses for Legionella Infection
Vignettes
Review
Article:
Sabria M, Yu VL. Hospital-acquired Legionellosis: Solution for a preventable infection. The Lancet Infectious
Diseases, 2:368-373, June 2002.
Review Article: Adhikari P,
Mietzner T. Cell Mediated Immunity. 2008.
Review Article: Greenberg D, Chiou CC, et
al. Problem pathogens: paediatric legionellosis-implications for
improved diagnosis. Lancet Infect Dis 2006;6:529-535.
Review Article: Pedro-Botet ML, et
al. Legionnaires' Disease contracted from patient homes: the coming of
the third plague? Eur J Clin Microbiol Infect Dis 2002;21(10):699-705.
Review Article:
Neil K,
Berkelman R. Increasing Incidence of
Legionellosis in the United States, 1990-2005: Changing Epidemiologic
Trends.Clin
Infect Dis. 2008 Sep 1;47(5):591-9.
Review Article: Pedro-Botet ML,
et al. Treatment strategies for Legionella Infection. Expert
Opin Pharmacother 2009;10:1109-1121.
Berger S.
Emergence of Infectious Diseases into the
21st Century, 2008.
Yu VL, Stout JE.
Community-Acquired Legionnaires' Disease: Implications
for Underdiagnosis and Laboratory Testing. Clin Infect Dis
2008;46:1365-1367.
Stout JE, Muder RR.
Role
of Environmental Surveillance in Determining the Risk of Hospital-Acquired
Legionellosis: A National Surveillance Study with Clinical Correlations.
Infect Control Hosp Epidemiol 2007;28:818-824.
Seenivasan MH, Yu VL, et al.
Legionnaires' Disease in Long-Term Care Facilities:
Overview and Proposed Solutions. JAGS 2005;53:875-880.
Griffin AT, et al.
Macrolides versus quinolones in Legionella pneumonia:
results from the Community-Acquired Pneumonia Organization international
study. Int J Tuberc Lung Dis. 2010 Apr;14:495-9.
Gudiol C, Verdaguer R, et al.
Outbreak of Legionnaires' Disease in Immunosuppressed
Patients at a Cancer Centre: Usefulness of Universal Urine Antigen Testing
and Early Levofloxacin Therapy. Clin Microbiol Infect. 2007
Nov;13:1125-8.
Neil K, et al.
Increasing Incidence of Legionellosis in the United
States, 1990-2005: Changing Epidemiologic Trends. Clin Infect
Dis. 2008 Sep 1;47:591-9.
Patel MC, et al.
L. micdadei PVE Successfully Treated with Levofloxacin/Valve
Replacement: Case Report and Review of the Literature. J Infect.
2005 Dec;51:e265-8.
Ng V, et al.
Our Evolving Understanding of Legionellosis Epidemiology:
Learning to Count. Clin Infect Dis. 2008 Sep 1;47:600-2.
Yu VL, Greenberg RN, et al.
Levofloxacin Efficacy in the Treatment of
Community-Acquired Legionellosis. Chest 2004;125
(6):2135-2139.
Stout JE. Preventing
Legionellosis. ASHRAE Journal. 2007:58-62.
Stout JE, Yu VL.
Experience of the First 16 Hospitals Using Copper-Silver
Ionization for Legionellosis Control: Implications for the Evaluation of
Other Disinfection Modalities. Infect Control Hosp
Epidemiol 2003;24 (8):563-568.
Pedro-Botet L, et al.
Legionella: macrolides or quinolones.
Clin Microbiol Infect 2006;12 (Suppl 3):25-30.
Authors
Miguel Sabria, M.D.,
Victor L. Yu, M.D.,
M. Luisa Pedro-Botet
Yu-Sen Eason Lin
First Edition (1998): Emanuel N. Vergis and
Victor L.
Yu
|
www.antimicrobe.org